Certain oncogenic drivers are strongly predictive of malignancy and aggressive thyroid cancer and as such can be considered “strong drivers.” These include BRAFV600E, TERT promoter mutations (C228T and C250T), and RET mutations as well as BRAF and RET‐related messenger RNA fusion transcripts. The gene discussed is RET; the disease is thyroid gland carcinoma.